PLPP6

Chr 9

phospholipid phosphatase 6

Also known as: LPRP-B, PA-PSP, PDP1, PPAPDC2, PSDP, bA6J24.6

The protein is a magnesium-independent polyisoprenoid diphosphatase that catalyzes dephosphorylation of presqualene, farnesyl, geranyl and geranylgeranyl diphosphates, functioning in cholesterol biosynthesis, protein prenylation, and innate immune response through neutrophil activation regulation. PLPP6 mutations cause autosomal recessive hypomyelinating leukodystrophy-15, a severe early-onset disorder affecting white matter development in the central nervous system. The gene shows low constraint against loss-of-function variants, consistent with its recessive inheritance pattern.

OMIMResearchSummary from RefSeq, UniProt
MultiplemechanismLOEUF 1.74
Clinical SummaryPLPP6
Population Constraint (gnomAD)
Low constraint (pLI 0.00) — loss-of-function variants are relatively tolerated in the population.
📋
ClinVar Variants
119 unique Pathogenic / Likely Pathogenic· 69 VUS of 200 total submissions

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Tolerant — LoF & missense variants common in population
LoF Constraint
1.74LOEUF
pLI 0.001
Z-score 0.21
OE 0.91 (0.471.74)
Tolerant

Highly tolerant — LoF variants common in population

Missense Constraint
-0.62Z-score
OE missense 1.13 (1.011.28)
190 obs / 167.6 exp
Tolerant

Tolerant to missense variation

Observed / Expected Ratios
LoF OE0.91 (0.471.74)
00.351.4
Missense OE1.13 (1.011.28)
00.61.4
Synonymous OE1.26
01.21.6
LoF obs/exp: 5 / 5.5Missense obs/exp: 190 / 167.6Syn Z: -1.86
DN
0.7034th %ile
GOF
0.6735th %ile
LOF
0.4331th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic112
Likely Pathogenic7
VUS69
Likely Benign5
Benign6
112
Pathogenic
7
Likely Pathogenic
69
VUS
5
Likely Benign
6
Benign

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
112
0
112
Likely Pathogenic
0
0
7
0
7
VUS
0
54
15
0
69
Likely Benign
0
3
0
2
5
Benign
0
3
3
0
6
Total0601372199

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PLPP6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →
Key Publications
Landmark & review papers · by relevance
PubMed
Top 1 results · since 2015Search PubMed ↗
Recent Gene-Specific Literature
Gene in title · MEDLINE · newest first
Europe PMC

No open access results found